BLOCK LISTING SIX MONTHLY RETURN
Date: 12 November 2025
|
Name of applicant: |
GSK plc |
|||
|
Name of scheme: |
GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan |
|||
|
Period of return: |
From: |
1 May 2025 |
To: |
31 October 2025 |
|
Balance of unallotted securities under scheme(s) from previous return: |
115,518 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see UKLR 20.6.7G): |
0 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
115,518 |
|||
|
Name of applicant: |
GSK plc |
|||
|
Name of scheme: |
GlaxoSmithKline plc Share Save Plan 2012 |
|||
|
Period of return: |
From: |
1 May 2025 |
To: |
31 October 2025 |
|
Balance of unallotted securities under scheme(s) from previous return: |
270,315 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see UKLR 20.6.7G): |
134,547 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
135,768 |
|||
|
Name of applicant: |
GSK plc |
|||
|
Name of scheme: |
GlaxoSmithKline plc Share Save Plan 2022 |
|||
|
Period of return: |
From: |
1 May 2025 |
To: |
31 October 2025 |
|
Balance of unallotted securities under scheme(s) from previous return: |
951,791 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see UKLR 20.6.7G): |
47,674 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
904,117 |
|||
|
Name of contact: |
Victoria Whyte |
|
Telephone number of contact: |
020 8047 5000 |